Perioperative Treatment of Resectable Liver Metastases (PERIMAX)
|ClinicalTrials.gov Identifier: NCT01540435|
Recruitment Status : Withdrawn (insufficient recruitment)
First Posted : February 28, 2012
Last Update Posted : May 29, 2013
University of Regensburg
University of Halle Medical Faculty
Information provided by (Responsible Party):
Hans J Schlitt, Prof. MD, University of Regensburg
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Actual Primary Completion Date :||May 2013|
|Actual Study Completion Date :||May 2013|
Stein A, Glockzin G, Wienke A, Arnold D, Edelmann T, Hildebrandt B, Hollerbach S, Illerhaus G, Königsrainer A, Richter M, Schlitt HJ, Schmoll HJ. Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature. BMC Cancer. 2012 Aug 16;12:356. doi: 10.1186/1471-2407-12-356. Review.